W. Messersmith
Impact in
-
- Drug Transport and Resistance Mechanisms
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- Cancer-related Molecular Pathways
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 7
- Cancer Treatment and Pharmacology 3
- Colorectal Cancer Treatments and Studies 3
- Pancreatic and Hepatic Oncology Research 1
-
- Angiogenesis and VEGF in Cancer 1
- Co-authors
- Alasdair Scott (1 shared paper)Antonio Jimeno (1 shared paper)Sharyn D. Baker (3 shared papers)Alex Sparreboom (1 shared paper)Shuiying Hu (1 shared paper)Sharon Marsh (1 shared paper)Vishal Lamba (1 shared paper)Antonio C. Wolff (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Drugs of today (1 paper)European Journal of Cancer (1 paper)Clinical Pharmacology & Therapeutics (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)
- Partner nations
- United StatesNetherlands
In The Last Decade
W. Messersmith
9 papers receiving 297 citations
Peers
Comparison fields: 5 of 48
- Oncology 161
- Pharmacology 43
- Pulmonary and Respiratory Medicine 67
- Hepatology 16
- Cancer Research 26
Countries citing papers authored by W. Messersmith
This map shows the geographic impact of W. Messersmith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Messersmith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Messersmith more than expected).
Fields of papers citing papers by W. Messersmith
This network shows the impact of papers produced by W. Messersmith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Messersmith. The network helps show where W. Messersmith may publish in the future.
Co-authors
The 25 scholars most cited alongside W. Messersmith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 140 | |
| 2 | 2015 | 125 | |
| 3 | 2009 | 13 | |
| 4 | 2006 | 11 | |
| 5 | 2009 | 7 | |
| 6 | 2012 | 3 | |
| 7 | 2006 | 2 | |
| 8 | 2008 | 1 | |
| 9 | 2010 | 1 |
About W. Messersmith
W. Messersmith is a scholar working on Oncology, Molecular Biology, Cancer Research, Pharmacology and Pathology and Forensic Medicine, having authored 9 papers that have together received 303 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Pharmacogenetics and Drug Metabolism (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Angiogenesis and VEGF in Cancer (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), Cancer Genomics and Diagnostics (1 paper) and Cancer Mechanisms and Therapy (1 paper). The work is most often cited by research in Oncology (161 citations), Pharmacology (43 citations), Pulmonary and Respiratory Medicine (67 citations), Hepatology (16 citations) and Cancer Research (26 citations). W. Messersmith has collaborated with scholars based in United States and Netherlands. Frequent co-authors include Alasdair Scott, Antonio Jimeno, Sharyn D. Baker, Alex Sparreboom, Shuiying Hu, Sharon Marsh, Vishal Lamba, Antonio C. Wolff, Jaap Verweij and R. J. Hansen. Their work appears in journals such as Journal of Clinical Oncology, Drugs of today, European Journal of Cancer, Clinical Pharmacology & Therapeutics and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.